Table 1. Ingenuity Pathway Analysis.
Function annotation | p-value | Number of molecules | |
---|---|---|---|
Abnormal muscle morphology | 1.03E-04 | 24 | |
Mitochondrial quantity | 4.80E-04 | 7 | |
Muscle mass | 8.22E-04 | 17 | |
Muscle function | 8.67E-04 | 23 | |
Oxidation of fatty acids | 2.92E-03 | 7 | |
Pathway annotation | |||
Oxidative phosphorylation | 2.71E-14 | 38 | |
Mitochondrial dysfunction | 2.71E-11 | 45 | |
Regulation | z-score | Direction | Number of molecules |
Oxidation of fatty acids | 2.20 | Down | 7 |
Upper part: The top-five annotated functions sorted by p-values and number of associated genes. Middle part: The top-tow annotated pathways sorted by p-values and number. Lower part: Gene transcripts annotated with oxidation of fatty acids were significantly down-regulated in T2D patients.